Author

Zofia Novotny Page 2

A cancer immunotherapy researcher who began working in laboratory science in 2000, Zofia Novotny runs CAR-T and tumor-model experiments at an academic lab in Boston, Massachusetts. She turned to bench research after briefly considering genetic counseling, holding degrees in molecular biology and biotechnology. A distance runner in her off hours, Novotny covers cancer therapy developments for Biology Insights.

NKX3.1: The Gene’s Role in Prostate Cancer
Immunophotonics: Diagnosis and Treatment with Light
What Are CT26 Cells Used For in Cancer Research?
The ERBB Family: Its Function and Role in Cancer
B16 Cells: A Key Model in Cancer Research
SOX10 and Melanoma: The Crucial Connection
4-1BB Ligand: A Key to Immune Response and Cancer Therapy
The ASPC-1 Cell Line for Pancreatic Cancer Research
What Is Autologous CAR T Cell Therapy and How Does It Work?
PC3 Cells: A Model for Advanced Prostate Cancer Research
4-1BB Antibody Clinical Trials: Status & Challenges
What Is a Neoepitope and Its Role in Cancer Therapy?
CCNE1 Amplification: What It Is and Its Role in Cancer
FFPE Tumor: Its Role in Cancer Diagnosis and Research
What Is TCR Therapy? How It Works and Its Applications
The VISTA Immune Checkpoint: A Target in Cancer Therapy
What Are the Approved T-Cell Engagers for Cancer?
TIGIT Clinical Trials for Cancer: A Status Update
What Is Anti-TIGIT Therapy and How Does It Work?
Why Was Saracatinib Discontinued for Cancer Treatment?
What Is CAR T-Cell Persistence and Why Is It Important?
What Is CAR T Expansion and Why Is It Important?
Two Hit Hypothesis: How Tumor Suppressor Genes Are Silenced
p53 Target Genes and Their Role in Cancer Biology
SKBR3: Notable Breakthroughs in Breast Cancer Cell Science
Cancer Mouse Models: Breakthroughs in Oncoimmunology
Prostate Cancer Cell Lines: Current Varieties & Key Traits